Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 4, 2011, Pages 411-421

  Sølling, Christoffer ^a,b   Christensen, A T ^a,b   Nygaard, U ^a,b   Krag, S ^a   Frokiaer J ^a,b   Wogensen, L ^a,b   Krog, J ^a,b   Tonnesen E K ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ERYTHROPOIETIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LAPAROTOMY; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RENAL ARTERY;

ANIMALS; APOPTOSIS; CASPASE 3; CYTOKINES; ENDOTOXEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPOPOLYSACCHARIDES; OXYGEN CONSUMPTION; RENAL CIRCULATION; RESUSCITATION; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952579223     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02396.x     Document Type: Article

References (32)

1. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2: 431-9.
2. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996; 11: 293-9.
3. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992; 72: 449-89.
4. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. J Am Med Assoc 2005; 293: 90-5. (Pubitemid 40066704)
5. Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 2008; 264: 405-32.
6. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-24. (Pubitemid 39031350)
7. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C. Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 2005; 75: 1100-5. (Pubitemid 43951373)
8. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-55. (Pubitemid 38195983)
9. Cuzzocrea S, Di PR, Mazzon E, Patel NS, Genovese T, Muia C, Crisafulli C, Caputi AP, Thiemermann C. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2006; 34: 1168-77.
10. Cunningham PN, Dyanov HM, Park P,Wang J, Newell KA, Quigg RJ. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-23. (Pubitemid 34556169)
11. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35: 585-92. (Pubitemid 37336877)
12. Mitra A, Bansal S, Wang W, Falk S, Zolty E, Schrier RW. Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant 2007; 22: 2349-53. (Pubitemid 47244715)
13. Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med 2009; 37: 889-98.
14. Brix-Christensen V, Gjedsted J, Andersen SK, Vestergaard C, Nielsen J, Rix T, Nyboe R, Andersen NT, Larsson A, Schmitz O, Tonnesen E. Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs. Acta Anaesthesiol Scand 2005; 49: 991-8. (Pubitemid 41076343)
15. Fenger-Eriksen C, Hartig RC, Kappel JT, Anker-Møller E, Heslop J, Frøkiaer J, Tønnesen E. Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005; 49: 969-74. (Pubitemid 41076340)
16. Forman CJ, Johnson DW, Nicol DL. Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int 2007; 99: 162-5. (Pubitemid 44915640)
17. Solling C, Christensen AT, Krag S, Froekiaer J,Wogensen L, Krog J, Toennesen E. Erythropoietin administration is associated with short-term improvement in GFR after ischemia-reperfusion injury. Acta Anaesthesiol Scand 2011; 55: 185-95.
18. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 2008; 36: S198-203.
19. Wan L, Bellomo R, Di GD, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003; 9: 496-502. (Pubitemid 37518649)
20. Bonventre JV. Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation. Contrib Nephrol 2007; 156: 39-46.
21. Granfeldt A, Ebdrup L, Tonnesen E, Wogensen L. Renal cytokine profile in an endotoxemic porcine model. Acta Anaesthesiol Scand 2008; 52: 614-20. (Pubitemid 351549577)
22. Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004; 22: 63-9. (Pubitemid 40228212)
23. Hojman P, Taudorf S, Lundby C, Pedersen BK. Erythropoietin augments the cytokine response to acute endotoxin-induced inflammation in humans. Cytokine 2009; 45: 154-7.
24. Poulsen TD, Andersen LW, Steinbruchel D, Gotze JP, Jorgensen OS, Olsen NV. Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23: 316-23.
25. Wu WT, Hu TM, Lin NT, Subeq YM, Lee RP, Hsu BG. Low-dose erythropoietin aggravates endotoxin-induced organ damage in conscious rats. Cytokine 2009; 49: 155-62.
26. Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77: 1020-30.
27. Le Minh K, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B. Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-{alpha} in acute liver failure of mice. Am J Pathol 2007; 170: 1954-63. (Pubitemid 47339269)
28. Kao R, Xenocostas A, Rui T, Yu P, Huang W, Rose J, Martin CM. Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit Care 2007; 11: R58.
29. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; CD007594.
30. Boldt J. PRO: hydroxyethylstarch can be safely used in the intensive care patient - the renal debate. Intensive Care Med 2009; 35: 1331-6.
31. Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010; 14: R40.
32. Johnson JP, Rokaw MD. Sepsis or ischemia in experimental acute renal failure: what have we learned? New Horiz 1995; 3: 608-14.